French drug major Sanofi’s dengue vaccine discovery could open a $-1 billion opportunity in India alone. The Paris-based global drug giant announced last week that it would have the vaccine......
Ending months of uncertainty, French pharma major Sanofi-aventis said on Wednesday it will buy US biotechnology giant Genzyme Corp for more than $20 billion.The proposed deal has been dragging due......
Sanofi-aventis on Mondaysaid it has extended its $18.5 billion offer for Genzyme for the second time, a move that will give the French drug-maker additional time to reach an agreement with US......